Search earnings tickers

GILD

2025Q2AMC

Gilead Sciences Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-08-07 · Fiscal end 2025-06-30 · Features as of 2025-08-07

← Earnings history

Street

Consensus EPS1.95

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move3.0%

IV front—

P/C full—

P/C front—

Features as of2025-08-07

Run-up

Close—

Ret 5d-1.8%

Ret 10d-2.6%

Ret 20d-3.7%

Ret 30d+4.1%

Print

Actual EPS

2.01Beat

Estimated EPS1.95

Actual revenue

7.1B

Surprise %+3.1%

Beat / missBeat

Beat streak 44

Beat streak 86

Reaction

1-day stock reaction+3.6%

Implied vs actual

Implied 3.0%Actual 4.5%

Gap reaction+4.5%

Day result+8.3%

Next-day upYes

Realized / IV1.50×

Post tape

Post 5d-0.9%

Post 10d-3.9%

Post volume13.1M

Vol ×10d1.97×

Vol ×20d2.26×

Post range5.7%